Literature DB >> 8191007

Effects of proligestone and megestrol on plasma adrenocorticotrophic hormone, insulin and insulin-like growth factor-1 concentrations in cats.

D B Church1, A D Watson, D R Emslie, D J Middleton, K Tan, D Wong.   

Abstract

This paper reports changes in adrenocorticotrophic hormone (ACTH), insulin and insulin-like growth factor-1 (IGF-1) concentrations in cats from a previously published study. The cats were given oral megestrol acetate (MA, 5 mg once daily for 14 days), subcutaneous proligestone (PRG, 100 mg on two occasions one week apart) or subcutaneous saline (1 ml as for PRG). In the cats given saline (n = 6), basal ACTH, insulin and IGF-1 did not change significantly throughout the following seven weeks. The cats given MA (n = 7) developed significant suppression of plasma ACTH concentrations and hyperinsulinaemia during treatment and for two to four weeks after MA dosage ceased. In the cats given PRG (n = 7), plasma ACTH concentrations were not significantly altered although three cats had markedly suppressed values for some time after PRG treatment had ceased. Serum insulin concentrations were not significantly altered in the PRG-treated cats. The results suggest PRG may be a preferable alternative to MA in some situations.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8191007     DOI: 10.1016/0034-5288(94)90101-5

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  5 in total

1.  Mammary fibroadenomatous hyperplasia in a young cat attributed to treatment with megestrol acetate.

Authors:  Lori D MacDougall
Journal:  Can Vet J       Date:  2003-03       Impact factor: 1.008

2.  Pasireotide for the Medical Management of Feline Hypersomatotropism.

Authors:  C J Scudder; R Gostelow; Y Forcada; H A Schmid; D Church; S J M Niessen
Journal:  J Vet Intern Med       Date:  2015-05-06       Impact factor: 3.333

3.  Hydrocortisone therapy in a cat with vasopressor-refractory septic shock and suspected critical illness-related corticosteroid insufficiency.

Authors:  Simone R R Pisano; Judith Howard; Horst Posthaus; Alan Kovacevic; Ivayla D Yozova
Journal:  Clin Case Rep       Date:  2017-05-31

4.  Pasireotide Long-Acting Release Treatment for Diabetic Cats with Underlying Hypersomatotropism.

Authors:  R Gostelow; C Scudder; S Keyte; Y Forcada; R C Fowkes; H A Schmid; D B Church; S J M Niessen
Journal:  J Vet Intern Med       Date:  2017-02-01       Impact factor: 3.333

5.  Dilated cardiomyopathy in a cat with congenital hyposomatotropism.

Authors:  Bérénice Lutz; Adeline Betting; Alan Kovacevic; Alexane Durand; Corinne Gurtner; Taina S Kaiponen; Hans Kooistra; Miguel Campos; Yi Cui
Journal:  JFMS Open Rep       Date:  2022-03-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.